BioDelivery Sciences International Inc (BDSI) Key Ratios
$5.59
$0.00 (0.00%)As on 31-Mar-2022 09:30EDT
Market cap
$577 Mln
Revenue (TTM)
$84 Mln
P/E Ratio
6.8
P/B Ratio
3.1
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -195.83 | -193.39 | -46.21 | 14.80 | 40.19 |
| EBIT | -2.30 | -27.31 | 12.57 | 52.82 | 20.88 |
| Net Profit | 858.01 | 526.62 | 230.07 | 65.17 | 26.69 |
| EPS | 848.72 | 538.78 | 239.16 | 51.42 | 21.57 |
| Book Value | -- | -- | 76.90 | 56.90 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Dec-21 | Dec-20 | Dec-19 |
| EBIT-Margin
| 15.57 | 0.15 | 22.27 | 21.07 | 3.36 |
| Net Margin
| 17.87 | -0.27 | 50.91 | 16.43 | -13.74 |
| Return on equity
| 18.48 | -48.04 | 57.33 | 28.89 | -30.76 |
| Return on Capital
| 13.63 | 1.46 | 39.17 | 16.32 | -14.60 |
| Return on Assets
| 10.58 | 0.96 | 30.07 | 12.16 | -10.50 |
| Debt to Equity (x)
| -- | -- | 0.31 | 0.72 | 0.84 |
Profitability
ROCE
39.17
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
|---|---|---|---|---|---|
|
BioDelivery Sciences International Inc (BDSI)
|
39.17
|
16.32
|
-14.60
|
-49.11
|
15.51
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
57.33
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
|---|---|---|---|---|---|
|
BioDelivery Sciences International Inc (BDSI)
|
57.33
|
28.89
|
-30.76
|
-175.39
|
-120.28
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROA
30.07
--
Profit after tax / Average Total assets * 100
|
Company Name
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
|---|---|---|---|---|---|
|
BioDelivery Sciences International Inc (BDSI)
|
30.07
|
12.16
|
-10.50
|
-34.45
|
7.53
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Margin
22.27
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
|---|---|---|---|---|---|
|
BioDelivery Sciences International Inc (BDSI)
|
22.27
|
21.07
|
3.36
|
-42.53
|
-3.40
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Margin
50.91
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
|---|---|---|---|---|---|
|
BioDelivery Sciences International Inc (BDSI)
|
50.91
|
16.43
|
-13.74
|
-60.88
|
5.92
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
0.07
--
Year on year growth in net sales
|
Company Name
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
|---|---|---|---|---|---|
|
BioDelivery Sciences International Inc (BDSI)
|
0.07
|
0.40
|
1.00
|
-0.10
|
2.99
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Growth
12.56
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
|---|---|---|---|---|---|
|
BioDelivery Sciences International Inc (BDSI)
|
12.56
|
781.71
|
115.81
|
-1,021.42
|
96.70
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
230.05
--
Year on year growth in profit after tax
|
Company Name
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
|---|---|---|---|---|---|
|
BioDelivery Sciences International Inc (BDSI)
|
230.05
|
267.99
|
54.81
|
-740.81
|
107.87
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EPS Growth
2.36
--
Year on year growth in earnings per share
|
Company Name
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
|---|---|---|---|---|---|
|
BioDelivery Sciences International Inc (BDSI)
|
2.36
|
2.33
|
0.66
|
-6.70
|
1.08
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.31
--
Total debt / Net worth
|
Company Name
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
|---|---|---|---|---|---|
|
BioDelivery Sciences International Inc (BDSI)
|
0.31
|
0.72
|
0.84
|
1.74
|
5.37
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.02
--
(Short term borrowings / Net worth)
|
Company Name
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
|---|---|---|---|---|---|
|
BioDelivery Sciences International Inc (BDSI)
|
0.02
|
0.72
|
--
|
--
|
5.37
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.37
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
|---|---|---|---|---|---|
|
BioDelivery Sciences International Inc (BDSI)
|
2.37
|
3.44
|
2.18
|
3.07
|
1.52
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Quick Ratio
2.08
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
|---|---|---|---|---|---|
|
BioDelivery Sciences International Inc (BDSI)
|
2.08
|
3.11
|
1.97
|
2.82
|
1.29
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
34.11
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
|---|---|---|---|---|---|
|
BioDelivery Sciences International Inc (BDSI)
|
34.11
|
30.77
|
34.82
|
24.49
|
14.28
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Asset Turnover
0.59
--
Sales / Average Total Assets
|
Company Name
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
|---|---|---|---|---|---|
|
BioDelivery Sciences International Inc (BDSI)
|
0.59
|
0.74
|
0.76
|
0.57
|
0.88
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Receivable days
115.05
--
Average Debtors / Sales * 365
|
Company Name
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
|---|---|---|---|---|---|
|
BioDelivery Sciences International Inc (BDSI)
|
115.05
|
101.47
|
85.94
|
73.78
|
36.60
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
321.56
--
Average Inventory / Sales * 365
|
Company Name
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
|---|---|---|---|---|---|
|
BioDelivery Sciences International Inc (BDSI)
|
321.56
|
212.91
|
141.41
|
133.03
|
88.61
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
640.52
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
|---|---|---|---|---|---|
|
BioDelivery Sciences International Inc (BDSI)
|
640.52
|
117.85
|
125.78
|
178.22
|
284.86
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
-203.92
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
|---|---|---|---|---|---|
|
BioDelivery Sciences International Inc (BDSI)
|
-203.92
|
196.53
|
101.57
|
28.60
|
-159.66
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
3.76
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
|---|---|---|---|---|---|
|
BioDelivery Sciences International Inc (BDSI)
|
3.76
|
17.15
|
-34.27
|
-6.88
|
31.26
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
1.70
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
|---|---|---|---|---|---|
|
BioDelivery Sciences International Inc (BDSI)
|
1.70
|
4.07
|
7.52
|
7.84
|
18.61
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
11.92
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
|---|---|---|---|---|---|
|
BioDelivery Sciences International Inc (BDSI)
|
11.92
|
10.07
|
41.32
|
-13.56
|
47.82
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|